Stay updated on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedHepatocellular carcinoma tag added and a new resource entry for the Genetic and Rare Diseases Information Center. Page revision updated to v3.5.0.SummaryDifference0.2%

- Check36 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded: Revision: v3.4.2. Removed: the funding-status notice and Revision: v3.4.1 banner. These changes do not affect the study details or the information presented on the page.SummaryDifference0.4%

- Check72 days agoChange DetectedNew site-wide notice about government funding and NIH operating status is displayed at the top of the page. The page header now shows a Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.4%

- Check79 days agoChange DetectedAdded a 'Show glossary' option. Updated metadata to display 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' entries.SummaryDifference0.2%

- Check93 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be a behind-the-scenes update with no impact on study content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.